Incidental Renal Cell Carcinoma Originating From a Native Kidney After En-bloc Resection for Adrenal Carcinoma in a Kidney Transplant Recipient

• Published in: Transplantation proceedings Vol. 46; no. 2; pp. 637 - 639
• Main Authors: Park, P, Kim, W.Y, Lee, J.B, Choi, S.B, Kim, W.B, Choi, S.Y
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 2014
• Subjects: Adrenal Cortex Neoplasms - surgery; Carcinoma, Renal Cell - diagnosis; Humans; Incidental Findings; Kidney Neoplasms - diagnosis; Kidney Transplantation; Male; Middle Aged; Neoplasms, Second Primary - diagnosis; Surgery
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2013.11.078

Abstract Background Renal transplantation is the best treatment for patients with end-stage renal disease. Although there is significantly increased risk of malignancy after renal transplantation, carcinoma of the native kidney is very rare, and moreover, the risk of endocrinologic malignancy after renal transplantation is lower than in the general population and adrenal cortical carcinoma extremely rare. We report a case of incidental renal cell carcinoma originating from a native kidney after en-bloc resection for adrenal carcinoma in a kidney transplant recipient. Case Report A 57 year-old male patient had undergone living-donor kidney transplantation for chronic renal failure from hypertension 15 years earlier and had a right adrenal tumor diagnosed on surveillance abdomen-pelvis computerized tomography. Based on 24-hour catecholamine laboratory findings, nonfunctioning tumor was suspected. The planned en-bloc resection of right adrenal gland and right native kidney combining the perirenal tissue and Gerota fascia was performed, because the tumor was suspicious for malignancy and could possibly invade the perirenal tissue or right kidney. On the final pathology, combined adrenal cortical carcinoma and incidental renal cell carcinoma was confirmed. Renal cell carcinoma was papillary, type I, and stage T1N0M0. Adrenal cortical carcinoma was 7.6 × 6.5 cm in size, had marked nuclear atypia, and was grade IV/IV. Mitotic counts were >10 per high-power field, but it had no capsular invasion or vascular invasion, and free resection margin was confirmed. In the preoperative period, he had taken immunosuppressants FK506 and mycophenolate sodium, but after combined carcinomas were confirmed, the regimen of combination of immunosuppressants was changed to sirolimus with low-dose FK506 and half-dose mycophenolate sodium.